Trials / Active Not Recruiting
Active Not RecruitingNCT05834894
Does Muscle Mass At Intensive Care Unit Admission Determine Mortality: the Memo Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (actual)
- Sponsor
- University Hospital, Geneva · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This retrospective monocentric study aims to investigate whether a low muscle mass at ICU admission and its loss over the ICU stay predicts mortality, and in what proportion we can counteract it by nutritional support.
Detailed description
The study hypothesis is that a low muscle mass at ICU admission, measured at the level of L3 on CT scans performed for clinical routine, and its change over the ICU stay predict the prognosis of the patient, especially the 30-day mortality, that it may at least be partly counteracted by nutritional support and that it is related with higher ICU and hospital costs. The objectives of this retrospective study are to determine: 1. the link between baseline body composition at ICU admission and outcomes, such as 30-day, ICU and hospital mortality and LOS, and infections. If this is confirmed, we aim to evaluate the added values of body composition to ICU severity scores to predict 30-day mortality 2. the link between baseline body composition vs. other locations to predict outcomes 3. the impact of body composition changes on the afore-mentioned outcomes. If this is confirmed, we aim to evaluate the added value of changes in body composition to changes in ICU severity scores to predict 30-day mortality 4. the impact of nutritional support on body composition changes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | exposure(s) of interest : intensive care unit | Low muscle mass is highly prevalent at hospital admission, and muscle mass generally decreases during hospital stay, especially in critically-ill patients. We would like to mesure muscle mas in critically ill patients and determine the association between outcomes. |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2025-05-31
- Completion
- 2025-10-31
- First posted
- 2023-04-28
- Last updated
- 2024-12-06
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05834894. Inclusion in this directory is not an endorsement.